Ahmedabad
(Head Office)Address : 506, 3rd EYE THREE (III), Opp. Induben Khakhrawala, Girish Cold Drink Cross Road, CG Road, Navrangpura, Ahmedabad, 380009.
Mobile : 8469231587 / 9586028957
Telephone : 079-40098991
E-mail: dics.upsc@gmail.com
Anaplastic Lymphoma Kinase (ALK)
Context: Lorlatinib, a Pfizer lung cancer drug, has reduced tumou progression in people with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
• Lung cancer is the leading cause of cancer deaths globally. NSCLC accounts for over 80% of lung cancer cases, with ALK-positive tumours accounting for about 5% of NSCLC.
• ALK-positive NSCLC mostly affects younger patients and is not strongly linked to smoking.
• It is very aggressive, with 25-40% of ALK-positive NSCLC patients developing brain metastases within two years. Brain metastases occur when cancer spreads from another part of the body to the brain.
Recent Current Affairs
Our Branches
Gandhinagar
Address: A-306, The Landmark, Urjanagar-1, Opp. Spicy Street, Kudasan – Por Road, Kudasan, Gandhinagar – 382421
Mobile : 9723832444 / 9723932444
E-mail: dics.gnagar@gmail.com
Vadodara
Address: 2nd Floor, 9 Shivali Society, L&T Circle, opp. Ratri Bazar, Karelibaugh, Vadodara, 390018
Mobile : 9725692037 / 9725692054
E-mail: dics.vadodara@gmail.com
Surat
Address: 403, Raj Victoria, Opp. Pal Walkway, Near Galaxy Circle, Pal, Surat-394510
Mobile : 8401031583 / 8401031587
E-mail: dics.surat@gmail.com
New Delhi(In Association with Edge IAS)
Address: 57/17, 2nd Floor, Old Rajinder Nagar Market, Bada Bazaar Marg, Delhi-60
Mobile : 9104830862 / 9104830865
E-mail: dics.newdelhi@gmail.com